Cargando…

Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

BACKGROUND: To determine whether early monitoring of the effects of bevacizumab in patients with recurrent high-grade gliomas, by a Perfusion Computed Tomography (PCT), may be a predictor of the response to treatment assessed through conventional MRI follow-up. METHODS: Sixteen patients were enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Maschio, Marta, Latagliata, Gaetano Marco, Anelli, Vincenzo, Piludu, Francesca, Carapella, Carmine Maria, Giovinazzo, Giuseppe, Marzi, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583244/ https://www.ncbi.nlm.nih.gov/pubmed/22494770 http://dx.doi.org/10.1186/1756-9966-31-33

Ejemplares similares

Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases
por: Di Nallo, Anna Maria, et al.
Publicado: (2009)

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
por: Maschio, Marta, et al.
Publicado: (2009)

Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas
por: Vaccaro, V., et al.
Publicado: (2014)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015)

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
por: Fabi, Alessandra, et al.
Publicado: (2009)

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
por: Fabi, Alessandra, et al.
Publicado: (2011)

Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study
por: Cordone, Iole, et al.
Publicado: (2017)

Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI
por: D’Urso, Pasqualina, et al.
Publicado: (2022)

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
por: Fabi, Alessandra, et al.
Publicado: (2012)

MRI-Based Radiomics to Differentiate between Benign and Malignant Parotid Tumors With External Validation
por: Piludu, Francesca, et al.
Publicado: (2021)

Magnetic resonance imaging-based prediction models for tumor stage and cervical lymph node metastasis of tongue squamous cell carcinoma
por: Vidiri, Antonello, et al.
Publicado: (2023)

Microenvironmental Factors in Oral Cavity Squamous Cell Carcinoma Undergoing Surgery: Correlation with Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced MRI
por: Vidiri, Antonello, et al.
Publicado: (2022)

Multiparametric MRI Evaluation of Oropharyngeal Squamous Cell Carcinoma. A Mono-Institutional Study
por: Piludu, Francesca, et al.
Publicado: (2021)

Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls
por: Cordone, Iole, et al.
Publicado: (2016)

How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature
por: Vasselli, Federica, et al.
Publicado: (2022)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

The Role of Patient- and Treatment-Related Factors and Early Functional Imaging in Late Radiation-Induced Xerostomia in Oropharyngeal Cancer Patients
por: Marzi, Simona, et al.
Publicado: (2021)

Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

Radiation-induced parotid changes in oropharyngeal cancer patients: the role of early functional imaging and patient−/treatment-related factors
por: Marzi, Simona, et al.
Publicado: (2018)

Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
por: Aquino, Domenico, et al.
Publicado: (2014)

Impact of epilepsy and its treatment on brain metastasis from solid tumors: A retrospective study
por: Maschio, Marta, et al.
Publicado: (2022)

A multiplanar complex resection of a low-grade chondrosarcoma of the distal femur guided by K-wires previously inserted under CT-guide: a case report
por: Zoccali, Carmine, et al.
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Clinical-radiomic models based on digital breast tomosynthesis images: a preliminary investigation of a predictive tool for cancer diagnosis
por: Murtas, Federica, et al.
Publicado: (2023)

Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
por: Netto, Joao Prola, et al.
Publicado: (2016)

Preliminary quantitative myocardial perfusion in response to cold pressor test in normals
por: Wang, Yi, et al.
Publicado: (2013)

Correlation between histogram-based DCE-MRI parameters and (18)F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes
por: Vidiri, Antonello, et al.
Publicado: (2020)

The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury
por: Kohen, Maryo Cenk, et al.
Publicado: (2018)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]
por: da Silva, Vinicius Trindade Gomes, et al.
Publicado: (2022)

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
por: Brandes, Alba A., et al.
Publicado: (2017)

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
por: Regazzo, Giulia, et al.
Publicado: (2016)

Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study
por: Bai, Xuexue, et al.
Publicado: (2022)

Correlation between musculoskeletal mass and perfusion in patients with gastrointestinal malignancy: a preliminary study based on quantitative CT and CT perfusion
por: Ji, Rui, et al.
Publicado: (2022)

Perfusion CT in Colorectal Cancer: Comparison of Perfusion Parameters with Tumor Grade and Microvessel Density
por: Kim, Jin Woong, et al.
Publicado: (2012)

The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion
por: Shen, Bairu, et al.
Publicado: (2022)

Correction: Correlation between musculoskeletal mass and perfusion in patients with gastrointestinal malignancy: a preliminary study based on quantitative CT and CT perfusion
por: Ji, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69s2aqvb4905nunnfpaqv8eo7v